Cargando…
Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis
The control of leishmaniases, a complex parasitic disease caused by the protozoan parasite Leishmania, requires continuous innovation at the therapeutic and vaccination levels. Chitosan is a biocompatible polymer administrable via different routes and possessing numerous qualities to be used in the...
Autores principales: | Loiseau, Philippe M., Pomel, Sébastien, Croft, Simon L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571104/ https://www.ncbi.nlm.nih.gov/pubmed/32916994 http://dx.doi.org/10.3390/molecules25184123 |
Ejemplares similares
-
GDP-Mannose Pyrophosphorylase: A Biologically Validated Target for Drug Development Against Leishmaniasis
por: Pomel, Sébastien, et al.
Publicado: (2019) -
Drugs used for the treatment of cerebral and disseminated infections caused by free‐living amoebae
por: Taravaud, Alexandre, et al.
Publicado: (2021) -
In vitro evaluation of antimicrobial agents on Acanthamoeba sp. and evidence of a natural resilience to amphotericin B
por: Taravaud, Alexandre, et al.
Publicado: (2017) -
Stimulation of Acanthamoeba castellanii excystment by enzyme treatment and consequences on trophozoite growth
por: Fechtali-Moute, Zineb, et al.
Publicado: (2022) -
The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates
por: Loiseau, Philippe M., et al.
Publicado: (2022)